September 22, 2017 12:04 AM ET


Company Overview of Rimonyx Pharmaceuticals, Ltd.

Company Overview

Rimonyx Pharmaceuticals, Ltd. engages in the discovery and development of drugs targeted at glycosaminoglycan and protein interactions. Its RX-111, an orally delivered small molecule drug for inflammatory bowel disease, is slated to enter Phase I clinical trials in the second quarter of 2005. Rimonyx Pharmaceuticals was founded by Paul Gregor in 2002. The company is based in Ness-Ziona, Israel.

Kiryat Weizmann Science Park

Sapir Street 7

Ness-Ziona,  70400


Founded in 2002


972 8 940 4593


972 8 940 0917

Key Executives for Rimonyx Pharmaceuticals, Ltd.

Founder, Chief Executive Officer and Director
Director of Medicinal Chemistry
Vice President of R & D
Scientific Advisor
Business Advisor and Director
Age: 66
Compensation as of Fiscal Year 2017.

Similar Private Companies By Industry

Company Name Region
Abital Pharma Pipelines Ltd. Middle East/Africa
Active PX Ltd. Middle East/Africa
Advanced Inhalation Technology Ltd. Middle East/Africa
Angio B Ltd. Middle East/Africa
Antaki Center for Herbal Medicine Ltd. Middle East/Africa

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Tax Management Inc United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Rimonyx Pharmaceuticals, Ltd., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at